Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections
- 17 June 2024
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 59 (2) , 127-133
Abstract
Background: Intravenous (IV) antibiotics have historically been considered standard of care for treatment of bloodstream infections (BSIs). Recent literature has shown sequential oral (PO) therapy to be noninferior to IV antibiotics for certain pathogens and disease states. However, a gap exists in the literature for BSI caused by Enterococcus faecalis. Objective: To compare outcomes of definitive sequential PO therapy to definitive IV therapy in patients with E faecalis BSI. Methods: Multicenter, retrospective, matched cohort study of adult patients with at least one blood culture positive for E faecalis from January 2017 to November 2022. Patients with polymicrobial BSI, concomitant infections requiring prolonged IV antibiotic therapy, those who did not receive antibiotic therapy, and those who died within 72 hours of index culture were excluded. Subjects were matched based on source of infection in a 2:1 (IV:PO) ratio. The primary outcome was a composite of all-cause mortality and treatment failure. Secondary outcomes included hospital length of stay (LOS), antibiotic duration, and 30-day readmission rate. Results: Of the 186 patients who met criteria for inclusion, there was no statistically significant difference in the primary composite outcome for PO compared to IV therapy (14.5% vs 21.8%; OR 0.53 [0.23-1.25]) or 30-day readmission (17.5% vs 29%; OR 0.53 [0.25-1.13]). Hospital LOS was significantly longer in patients receiving IV-only therapy (6 days vs 14 days; P < 0.001). Conclusion and Relevance: Sequential oral therapy for E faecalis BSI had similar outcomes compared to IV-only treatment and may be considered in eligible patients.Keywords
This publication has 25 references indexed in Scilit:
- Oral antibiotic step-down therapy for nonstaphylococcal gram-positive bloodstream infectionsDiagnostic Microbiology and Infectious Disease, 2023
- Pharmacoeconomic and antimicrobial stewardship analysis in waste management: Beyond switching drug administration routeAmerican Journal of Infection Control, 2023
- A Retrospective Analysis of Intravenous vs Oral Antibiotic Step‐Down Therapy for the Treatment of Uncomplicated Streptococcal Bloodstream InfectionsThe Journal of Clinical Pharmacology, 2022
- Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic ReviewThe American Journal of Medicine, 2021
- Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae BacteremiaJAMA Internal Medicine, 2019
- Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2018
- Intravenous‐only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae‐Associated Bacteremic Urinary Tract InfectionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infectionsInternational Journal of Antimicrobial Agents, 2016
- Budget Impact Analysis of Conversion from Intravenous to Oral Medication When Clinically Eligible for Oral IntakeClinical Therapeutics, 2011
- Cost of bloodstream infectionsAmerican Journal of Infection Control, 2008